August 9, 2018 / 12:03 PM / 12 days ago

India's Aurobindo Pharma Q1 profit misses estimates

Aug 9 (Reuters) - Aurobindo Pharma Ltd reported a 12 percent fall in quarterly profit on Thursday and missed analysts’ expectations, hurt by higher expenses.

Net profit was 4.56 billion rupees ($66.40 million) in the first quarter ended June 30, compared with 5.19 billion rupees a year earlier, the Hyderabad-headquartered company said in a statement bit.ly/2MdMEAt.

Analysts on average had expected a net profit of 5.29 billion rupees, according to estimates by Thomson Reuters I/B/E/S.

Expenses rose 24.4 percent to 37.23 billion rupees, while revenue from operations stood at 41.82 billion rupees. ($1 = 68.6750 Indian rupees) (Reporting by Sharnya G and Chris Thomas in Bengaluru; Editing by Subhranshu Sahu)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below